Drug Database
Back to search

France· FR:63633204

NICOTINAMIDE RENAUDIN 100 mg/2 mL, solution injectable

A nicotinamide product containing nicotinamide, registered in France by LABORATOIRE RENAUDIN. The same ATC class is registered in 8 of our 19 countries.

ATC A11HA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNICOTINAMIDE RENAUDIN 100 mg/2 mL, so…ATCA11HA01REGISTER NO.FR:63633204PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nicotinamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nicotinamide is registered in 8 of 19 countries.

Countries holding a registration under ATC A11HA01 (nicotinamide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search nicotinamide products by name

Nicotinamide · ATC A11HA01

8 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
NICOTINAMIDE
Manufacturer
LABORATOIRE RENAUDIN
Country
France (FR)
ATC code
A11HA01
ATC class
Nicotinamide
Defined daily dose
0.15 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400927448515
    10 ampoule(s) en verre de 2 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

83 interactions on record for nicotinamide.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nicotinamide against other medicinesHow interaction checks work

Nicotinamide · interactions on record

83 records

  • 7 severe
  • 75 moderate
  • 1 minor

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nicotinamide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nicotinamide products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Nicotinamide Sterop
  • Germany · Nicotinamid Axicur
  • United Kingdom (Northern Ireland) · Freederm, Freederm Treatment
  • Ireland · Nicam
  • Italy · Nicotinamide Idi
  • Poland · Vitaminum Pp Polfarmex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdf43559-ed8e-4391-83e6-188ff4115cf1
GET /v1/drugs/cdf43559-ed8e-4391-83e6-188ff4115cf1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63633204",
  "date_amm": "2013-09-06",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "NICOTINAMIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about nicotinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console